Cure My Disease

Don't miss your cure!

 Log in / Sign up

Home visits by midwives may boost breastfeeding and sleep in new moms

NCT ID NCT07773207

Symptom relief Sponsor: Serap Öner Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time

Summary

This trial tests whether a structured program led by midwives—including a pre-discharge education session, a home visit in the second week, and a phone call in the fourth week—can improve breastfeeding confidence, sleep quality, and mother-infant bonding in new mothers. About 98 women who recently gave birth will be randomly assigned to receive either this extra support or routine postpartum care. The study measures changes in breastfeeding self-efficacy, sleep, and maternal attachment from baseline to six weeks after birth.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Midwife-led home-based postpartum follow-up program (education, home visit, and phone support)
What this could lead to
If effective, this program could become a standard approach to support new mothers, improving breastfeeding success, sleep, and emotional bonding.
What could go wrong
The trial is relatively small and results may not apply to all settings. The program's success depends on midwife availability and may not show clear benefits over routine care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

98 people

The number who actually took part.

Started

Feb 2026

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 years or older Delivered a singleton live-born infant at term (37 weeks of gestation or later) Intended to breastfeed Able to communicate in Turkish Provided written informed consent Both the mother and infant were medically stable and eligible for discharge following routine postpartum care Exclusion Criteria: * A maternal or infant medical condition contraindicating breastfeeding A severe maternal or infant complication requiring prolonged hospitalization or intensive care A diagnosed maternal psychiatric disorder that could interfere with participation Inability to participate in the scheduled follow-up procedures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast feeding are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Breast Feeding

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast feeding Postpartum period

Contacts and locations

Locations

  • Elazig Fethi Sekin City Hospital

    Elazig, Turkey, Elâzığ, 23280, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.